E-LIB Suche - Ergebnisse für: McBride, Ali

1

Real-World Use of Fedratinib for Myelofibrosis Following Pr..:

Mascarenhas, John ; Harrison, Claire ; Schuler, Tammy A....
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 2 - p. 122-132 , 2024

Link: https://doi.org/10.1016/..

2

Treatment patterns and outcomes with luspatercept in patien..:

Mukherjee, Sudipto ; Brown‐Bickerstaff, Cherrishe ; Falkenstein, Angelica...
HemaSphere. 8 (2024) 1 - p. , 2024

Link: https://doi.org/10.1002/..

3

Corrigendum to "Real-world clinical outcomes with enasideni..:

Klink, Andrew J. ; Gajra, Ajeet ; Knoth, Russell L....
Leukemia Research. 136 (2024) - p. 107430 , 2024

Link: https://doi.org/10.1016/..

4

Clinical Outcomes and Healthcare Resource Utilization for P..:

Garcia-Manero, Guillermo ; Matsuno, Rayna K. ; McBride, Ali...
Clinical Lymphoma Myeloma and Leukemia. , 2024

Link: https://doi.org/10.1016/..

5

Economic burden during remission and after relapse among ol..:

Brunner, Andrew M. ; Huggar, David ; Copher, Ronda...
Leukemia Research. 132 (2023) - p. 107353 , 2023

Link: https://doi.org/10.1016/..

6

Defining ruxolitinib failure and transition to next-line th..:

Mascarenhas, John ; Nguyen, Hiep ; Saunders, Ashley...
Future Oncology. 19 (2023) 11 - p. 763-773 , 2023

Link: https://doi.org/10.2217/..

7

P733: TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH L..:

Mukherjee, Sudipto ; Brown-Bickerstaff, Cherrishe ; Huggar, David...
HemaSphere. 7 (2023) S3 - p. e648138a , 2023

Link: https://doi.org/10.1097/..

8

PB2017: CLINICAL OUTCOMES BY SF3B1 MUTATION STATUS IN PATIE..:

Garcia-Manero, Guillermo ; Matsuno, Rayna K. ; Mcbride, Ali...
HemaSphere. 7 (2023) S3 - p. e20066a9 , 2023

Link: https://doi.org/10.1097/..

9

P515: A REAL-WORLD EVALUATION OF TREATMENT PATTERNS AND OUT..:

Maher, Keri ; Brown-Bickerstaff, Cherrishe ; Qiu, Ying...
HemaSphere. 7 (2023) S3 - p. e682228c , 2023

Link: https://doi.org/10.1097/..

10

POSTER: AML-547 Prognostic Effect of Co-Mutations on Patien..:

Maciejewski, Jaroslaw ; Pollyea, Daniel ; Roboz, Gail...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S164 , 2023

Link: https://doi.org/10.1016/..

11

Zanubrutinib in Mantle Cell Lymphoma Management: A Comprehe..:

Alsuhebany, Nada ; Pan, Congshan ; Holovac, Eileen..
Blood and Lymphatic Cancer: Targets and Therapy. 13 (2023) - p. 67-76 , 2023

Link: https://doi.org/10.2147/..

12

P589: IMPLICATIONS OF REGISTRY DATA FOR ACUTE MYELOID LEUKE..:

Scott, Bart ; Sekeres, Mikkael ; Garcia-Manero, Guillermo...
HemaSphere. 7 (2023) S3 - p. e5950536 , 2023

Link: https://doi.org/10.1097/..

13

POSTER: MDS-065 Treatment Patterns and Transfusion Outcomes..:

Mukherjee, Sudipto ; Brown-Bickerstaff, Cherrishe ; Huggar, David...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S180 , 2023

Link: https://doi.org/10.1016/..

14

AML-547 Prognostic Effect of Co-Mutations on Patients With ..:

Maciejewski, Jaroslaw ; Pollyea, Daniel ; Roboz, Gail...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S311-S312 , 2023

Link: https://doi.org/10.1016/..

15

Pharmacist biosimilar survey reveals knowledge gaps:

Stevenson, James G. ; McCabe, Dorothy ; McGrath, Melissa.
Journal of the American Pharmacists Association. 63 (2023) 2 - p. 529-537.e7 , 2023

Link: https://doi.org/10.1016/..